Steven Zelenkofske - 19 Jan 2023 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ Steven Zelenkofske
Issuer symbol
CVKD
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
3
Filing time
19 Jan 2023, 19:31:54 UTC
Next filing
19 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVKD Common Stock 40,000 19 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVKD Stock Options 19 Jan 2023 Common Stock 50,000 $0.6400 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.